argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
| Website | http://www.argenx.com |
| Ticker | NASDAQ:ARGX |
| Revenue | $1.9 billion |
| Employees | 1,737 (1,737 on RocketReach) |
| Founded | 2008 |
| Address | 33 Arch Street Suite 3201, Boston, Massachusetts 02110, US |
| Phone | +32 477 77 29 44 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+33 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Differentiated antibodies, Science and Engineering, Niche indications, Clinical Trials, Oncology, Health Care, Autoimmune diseases, Therapeutics, Antibody-based drugs |
| Web Rank | 2 Million |
| Keywords | Immunology, Autoimmune Diseases, Biotechnology, Therapeutics, Pharmaceutical, Drug Development, Immunotherapy, Biopharma, Clinical Trials, Antibodies, Research, Biologics, Global Health, Precision Medicine, Patient Care, Healthcare, Rare Diseases, Innovation, Science, Medicine |
| Competitors | Roche, Novartis, Sanofi, AstraZeneca, Bristol Myers Squibb, Merck Group, Pfizer, Amgen, Lilly India, Genmab +43 more (view full list) |
Looking for a particular argenx employee's phone or email?
The argenx annual revenue was $1.9 billion in 2026.
Karl G is the CFO of argenx.
1,737 people are employed at argenx.
argenx is based in Boston, Massachusetts.